Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference
BUFFALO, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Month: January 2021
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020
Monthly information regarding the total number of voting rights and total number of shares of…
Plus Therapeutics to Participate in Upcoming January Conferences
AUSTIN, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
CANTON, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
Focus on Women’s Health, Oncology, Mental Health to Improve Execution and Accelerate Growth SALT LAKE CITY,…
RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
Glen Rock, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx”…
Histogen Announces Closing of $14.0 Million Upsized Public Offering
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics…
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences in January
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
Kymera Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021
WATERTOWN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical…
Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial
CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq:…
Inventiva announces design of Phase III clinical trial with lanifibranor in NASH
A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg…
CORRECTION — Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — In a release issued under the same…
CORRECTING and REPLACING – GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — In a release issued earlier…
OSE Immunotherapeutics Presentation at H.C. Wainwright BIOCONNECT 2021 Virtual Conference
NANTES, France, Jan. 05, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today…
Sidetrade ranked a “Major Player” in the order-to-cash market by IDC
Sidetrade (Euronext Growth: ALBFR.PA), the artificial intelligence platform dedicated to accelerating company revenue and cashflow,…
John Snow Labs Announces State-of-the-Art Enhancements to its Spark NLP Technology, Resulting in 2.5M Downloads and 9x Growth in 2020
Spark NLP ranked by data scientists as the most popular and accurate NLP solution on…
Goodbody Boosts Marketing Agility with Progress
With Progress Sitefinity Cloud, Ireland’s leading brokerage quadrupled its account openings through customer-centric digital transformation…
Exterro Granted Patent for Ground-Breaking Gateway Coordinator Technology
The company’s game-changing technology innovation optimizes data collection, processing, and transfer of on-premises data to…